{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:32:57Z","timestamp":1792290777213,"version":"4.4.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12902-015-0077-3","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T23:35:07Z","timestamp":1450136107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study"],"prefix":"10.1186","volume":"15","author":[{"given":"Yukio","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Mukaiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeharu","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,15]]},"reference":[{"issue":"Suppl 2","key":"77_CR1","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1002\/jbmr.5650081308","volume":"8","author":"C Christiansen","year":"1993","unstructured":"Christiansen C. Skeletal osteoporosis. J Bone Miner Res. 1993;8 Suppl 2:S475\u201380. Review.","journal-title":"J Bone Miner Res"},{"key":"77_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.0105-2896.2005.00327.x","volume":"208","author":"S Tanaka","year":"2005","unstructured":"Tanaka S, Nakamura K, Takahasi N, Suda T. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev. 2005;208:30\u201349.","journal-title":"Immunol Rev"},{"key":"77_CR3","doi-asserted-by":"crossref","unstructured":"Rinotas V, Niti A, Dacquin R, Bonnet N, Stolina M, Han CY, Kostenuik P, Jurdic P, Ferrari S, Douni E. Novel genetic models of osteoporosis by overexpression of human RANKL in transgenic mice. J Bone Miner Res. 2013 Epub ahead of print.","DOI":"10.1002\/jbmr.2112"},{"key":"77_CR4","first-page":"47","volume":"10","author":"G Iolascon","year":"2013","unstructured":"Iolascon G, Napolano R, Gioia M, Moretti A, Riccio I, Gimigliano F. The contribution of cortical and trabecular tissues to bone strength: Insights from denosumab studies. Clin Cases Miner Bone Metab. 2013;10:47\u201351.","journal-title":"Clin Cases Miner Bone Metab"},{"key":"77_CR5","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1210\/jc.2013-1597","volume":"98","author":"HG Bone","year":"2013","unstructured":"Bone HG, Chapurlat R, Brandi ML, Brown JP, Czerwinski E, Krieg MA, et al. The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension. J Clin Endocrinol Metab. 2013;98:4483\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"77_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2165\/11203300-000000000-00000","volume":"28","author":"MD Moen","year":"2011","unstructured":"Moen MD, Keam SJ. Denosumab: A review of its use in the treatment of postmenopausal osteoporosis. Drugs Aging. 2011;28:63\u201382.","journal-title":"Drugs Aging"},{"key":"77_CR7","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/AOG.0b013e318291718c","volume":"121","author":"C Recknor","year":"2013","unstructured":"Recknor C, Czerwinski E, Bone HG, Bonnick SL, Binkley N, Palacios S, et al. Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: A randomized open-label trial. Obstet Gynecol. 2013;121:1291\u20139.","journal-title":"Obstet Gynecol"},{"key":"77_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bone.2013.10.006","volume":"58","author":"C Roux","year":"2014","unstructured":"Roux C, Hofbauer LC, Ho PR, Wark JD, Zillikens MC, Fahrleitner-Pammer A, et al. Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study. Bone. 2014;58:48\u201354.","journal-title":"Bone"},{"key":"77_CR9","doi-asserted-by":"publisher","first-page":"E487","DOI":"10.1210\/jc.2014-3594","volume":"100","author":"S Palacios","year":"2015","unstructured":"Palacios S, Agodoa I, Bonnick S, Van den Bergh JP, Ferreira I, Ho PR, et al. Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate. J Clin Endocrinol Metab. 2015;100:E487\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"77_CR10","doi-asserted-by":"crossref","unstructured":"Gallagher JC, Jindal P, Lynette MS. Vitamin D does not Increase Calcium Absorption in Young Women: A Randomized Clinical Trial. J Bone Miner Res. 2013 Epub ahead of print.","DOI":"10.1002\/jbmr.2121"},{"key":"77_CR11","doi-asserted-by":"crossref","first-page":"582S","DOI":"10.1093\/ajcn\/88.2.582S","volume":"88","author":"G Jones","year":"2008","unstructured":"Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88:582S\u20136S.","journal-title":"Am J Clin Nutr"},{"key":"77_CR12","first-page":"323","volume":"24","author":"S Soen","year":"2014","unstructured":"Soen S. New diagnostic criteria and guidelines on osteoporosis. Diagnostic criteria for primary osteoporosis : Year 2012 revision. (Article in Japanese). Clin Calcium. 2014;24:323\u20139.","journal-title":"Clin Calcium"},{"key":"77_CR13","first-page":"377","volume":"23","author":"T Okano","year":"2013","unstructured":"Okano T. [Clinical application of serum 25OHD]. Clin Calcium. 2013;23:377\u201384. Article in Japanese.","journal-title":"Clin Calcium"},{"issue":"7 Suppl","key":"77_CR14","first-page":"3","volume":"34","author":"R Civitelli","year":"2011","unstructured":"Civitelli R, Ziambaras K. Calcium and phosphate homeostasis: Concerted interplay of new regulators. J Endocrinol Invest. 2011;34(7 Suppl):3\u20137.","journal-title":"J Endocrinol Invest"},{"key":"77_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s001980050214","volume":"10","author":"M Shiraki","year":"1999","unstructured":"Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Taga M, Nakamura T, et al. A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group. Osteoporos Int. 1999;10:183\u201392.","journal-title":"Osteoporos Int"},{"key":"77_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s002239900702","volume":"65","author":"KH Lau","year":"1999","unstructured":"Lau KH, Baylink DJ. Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int. 1999;65:295\u2013306.","journal-title":"Calcif Tissue Int"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-015-0077-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-015-0077-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-015-0077-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T02:09:53Z","timestamp":1718244593000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-015-0077-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["77"],"URL":"https:\/\/doi.org\/10.1186\/s12902-015-0077-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"81"}}